Looking Back at BrightInsight's 2021

It's been another unprecedented year, and although 2021 presented plenty of challenges, it’s also been a year full of opportunity. Biopharma and medtech companies are doubling down on digital health and consumers are adopting new technologies at a rapid pace–and we’re thrilled to be part of this exciting era in healthcare.

In 2021 alone, BrightInsight launched and supported digital health solutions, including 5 Software as a Medical Device (SaMD) with a variety of biopharma clients, AstraZeneca, CSL BehringRoche, and Novo Nordisk.

Here's a quick look at our 2021 accomplishments.

We are so excited to keep building momentum in the new year, and we can't wait to see the healthcare market continue to learn the value of digital health and investment in the sector.

Back to Blog